Abbott’s Xience Skypoint stent. [Image from Abbott]Abbott (NYSE:ABT) announced today that its Xience Skypoint drug-eluting stent platform is now available globally.
Xience Skypoint has received FDA approval, CE mark and PMDA approval in Japan for the broadest expansion with the availability of extended sizes of 4.5 mm and 5 mm offerings.